ClinVar Miner

Submissions for variant NM_006231.4(POLE):c.862G>A (p.Ala288Thr)

dbSNP: rs1593079445
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001018101 SCV001179288 uncertain significance Hereditary cancer-predisposing syndrome 2019-02-28 criteria provided, single submitter clinical testing The p.A288T variant (also known as c.862G>A), located in coding exon 9 of the POLE gene, results from a G to A substitution at nucleotide position 862. The alanine at codon 288 is replaced by threonine, an amino acid with similar properties. In one study, this alteration was detected in 1/431 patients with microsatellite stable colorectal cancer who were tested for POLE mutations (Stenzinger A et al. Cancer Med, 2014 Dec;3:1527-38). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.